The lilly-palooza

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

HOW AI IS SUPERCHARGING THE SECTOR

CITY

At the end of last year, I was approached by BlueCo Healthcare to join their team providing digital weight management services across the NHS, insurance and the private sector. I was initially uncerta

Out of puff: Second-quarter revenue at Connecticut-based Marlboro-maker Philip Morris International (PMI) rose 7.1% from a year earlier, to $10.1bn – slightly short of analysts’ expectations of $10.3b

A DECADE AGO, while L’Oréal stood as the ...